Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
11326
CALL
Invesco S&P 500 GARP ETF
SPGP
$2.09B
| $204K | ﹤0.01% |
1,900
+100
| +6% | +$11.4K |
2023 Q1
12 quarters
|
|
11327
PUT
Centuri Holdings
CTRI
$2.11B
| $204K | ﹤0.01% |
+7,000
| New | +$204K |
2026 Q1
0 quarters
|
|
|
SMCY
11328
CALL
YieldMax SMCI Option Income Strategy ETF
SMCY
$147M
| $204K | ﹤0.01% |
37,300
+9,700
| +35% | +$73.7K |
2024 Q4
5 quarters
|
|
|
NSCR
11329
DELISTED
Nuveen Sustainable Core ETF
NSCR
| $204K | ﹤0.01% |
+7,107
| New | +$219K |
2026 Q1
0 quarters
|
|
|
AAT
11330
CALL
American Assets Trust
AAT
$1.32B
| $204K | ﹤0.01% |
+11,100
| New | +$208K |
2026 Q1
0 quarters
|
|
11331
PUT
ProShares UltraShort Euro
EUO
$35.2M
| $204K | ﹤0.01% |
+6,900
| New | +$198K |
2026 Q1
0 quarters
|
|
|
AFBI
11332
DELISTED
Affinity Bancshares
AFBI
| $204K | ﹤0.01% |
+9,174
| New | +$184K |
2026 Q1
0 quarters
|
|
11333
PUT
ABM Industries
ABM
$2.87B
| $204K | ﹤0.01% |
5,300
-3,100
| -37% | -$134K |
2020 Q3
22 quarters
|
|
|
GMOD
11334
GMO Dynamic Allocation ETF
GMOD
$43.9M
| $204K | ﹤0.01% |
+7,863
| New | +$208K |
2026 Q1
0 quarters
|
|
11335
CALL
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$731M
| $204K | ﹤0.01% |
5,000
-1,200
| -19% | -$50.3K |
2025 Q4
1 quarter
|
|
|
FT
11336
Franklin Universal Trust
FT
$178M
| $204K | ﹤0.01% |
25,457
+15,052
| +145% | +$122K |
2025 Q4
1 quarter
|
|
11337
PUT
Teekay
TK
$1.3B
| $204K | ﹤0.01% |
16,700
-7,600
| -31% | -$83.8K |
2013 Q2
51 quarters
|
|
11338
First Community Bankshares
FCBC
$908M
| $204K | ﹤0.01% |
4,911
-2,997
| -38% | -$114K |
2024 Q4
5 quarters
|
|
11339
PUT
CapForce IBD 50 ETF
FFTY
$76.1M
| $204K | ﹤0.01% |
6,100
-100
| -2% | -$3.71K |
2025 Q4
1 quarter
|
|
11340
CALL
Invesco CurrencyShares British Pound Sterling Trust
FXB
$82.7M
| $204K | ﹤0.01% |
1,600
-1,500
| -48% | -$194K |
2025 Q4
1 quarter
|
|
|
IREX
11341
Tradr 2X Long IREN Daily ETF
IREX
$60.7M
| $204K | ﹤0.01% |
+11,748
| New | +$440K |
2026 Q1
0 quarters
|
|
11342
CALL
Sidus Space
SIDU
$183M
| $204K | ﹤0.01% |
+87,800
| New | +$239K |
2026 Q1
0 quarters
|
|
|
DIVE
11343
Dana Concentrated Dividend ETF
DIVE
$45.9M
| $204K | ﹤0.01% |
+8,439
| New | +$215K |
2026 Q1
0 quarters
|
|
|
COTG
11344
Leverage Shares 2X Long COST Daily ETF
COTG
$7.77M
| $204K | ﹤0.01% |
+13,659
| New | +$198K |
2026 Q1
0 quarters
|
|
11345
Cardiff Oncology
CRDF
$87.1M
| $203K | ﹤0.01% |
125,566
+7,378
| +6% | +$15.2K |
2025 Q3
2 quarters
|
|
|
BCPC
11346
PUT
Balchem Corp
BCPC
$5.31B
| $203K | ﹤0.01% |
+1,200
| New | +$204K |
2026 Q1
0 quarters
|
|
11347
CALL
Enanta Pharmaceuticals
ENTA
$377M
| $203K | ﹤0.01% |
16,100
-2,100
| -12% | -$28.2K |
2025 Q3
2 quarters
|
|
11348
The Beachbody Company
BODI
$35.8M
| $203K | ﹤0.01% |
+18,342
| New | +$183K |
2026 Q1
0 quarters
|
|
11349
CALL
Rani Therapeutics
RANI
$93.6M
| $203K | ﹤0.01% |
276,600
+63,100
| +30% | +$80.6K |
2025 Q4
1 quarter
|
|
|
AVNS
11350
CALL
DELISTED
Avanos Medical
AVNS
| $203K | ﹤0.01% |
+14,500
| New | +$195K |
2026 Q1
0 quarters
|
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.